Approval · Notice of Compliance 21510 · 2018
KAMRAB: Notice of Compliance 21510
Issued November 7, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21510
- Date
- November 7, 2018
- Company
- Kamada LtdKiryat Weizmann Science Park, Rehovot, Israel
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- RABIES IMMUNOGLOBULIN, HUMAN 150 UNIT per ML